GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CTXR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Citius Pharmaceuticals Inc stock price on Friday moving 13.69% between high and low
(Updated on Apr 19, 2024)

Sell candidate since Apr 18, 2024 Loss -6.34% PDF

The Citius Pharmaceuticals Inc stock price fell by -6.34% on the last day (Friday, 19th Apr 2024) from $0.81 to $0.754. During the last trading day the stock fluctuated 13.69% from a day low at $0.724 to a day high of $0.82. The price has fallen in 9 of the last 10 days and is down by -24.51% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 million shares and in total, 2 million shares were bought and sold for approximately $1.26 million.

Given the current short-term trend, the stock is expected to rise 28.35% during the next 3 months and, with a 90% probability hold a price between $0.97 and $1.39 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CTXR Signals & Forecast

There are few to no technical positive signals at the moment. The Citius Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.787 and $0.81. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -26.76%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Citius Pharmaceuticals Inc stock

Citius Pharmaceuticals Inc finds support from accumulated volume at $0.736 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0992 between high and low, or 13.69%. For the last week the stock has had daily average volatility of 14.36%.

Citius Pharmaceuticals Inc is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTXR) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Citius Pharmaceuticals Inc to open at $0.767, and during the day (based on 14 day Average True Range), to move between $0.664 and $0.84, which gives a possible trading interval of +/-$0.0902 (+/-11.96%) up or down from last closing price. If Citius Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 23.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.736 (2.39%) than the resistance at $0.795 (5.40%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Citius Pharmaceuticals Inc stock A Buy?

The Citius Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Citius Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -5.477 Strong Sell Candidate Unchanged

Predicted Opening Price for Citius Pharmaceuticals Inc of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.767 ( 1.73%) $0.754

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CTXR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.87 14.88 %
R2 0.83 9.86 %
R1 0.81 6.76 %
Current price: 0.754
Support S1 0.730 -3.29 %
S2 0.706 -6.39 %
S3 0.668 -11.42 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.90 18.94 %
R2 0.81 6.77 %
R1 0.795 5.40 %
Current price 0.754
Support S1 0.736 -2.39%
S2 0.669 -11.36%
S3 0.640 -15.15%

FAQ

What is the symbol for Citius Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Citius Pharmaceuticals Inc is CTXR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Citius Pharmaceuticals Inc Stock?
The Citius Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Citius Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Citius Pharmaceuticals Inc Stock?
Citius Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Citius Pharmaceuticals Inc Stock.

What's the current price of Citius Pharmaceuticals Inc Stock?
As of the end of day on the 2024-04-19, the price of an Citius Pharmaceuticals Inc (CTXR) share was $0.754.

What is the 52-week high and low for Citius Pharmaceuticals Inc Stock?
The 52-week high for Citius Pharmaceuticals Inc Stock is $1.61 and the 52-week low is $0.600.

What is the market capitalization of Citius Pharmaceuticals Inc Stock?
As of the 2024-04-19, the market capitalization of Citius Pharmaceuticals Inc is 129.853M.

When is the next earnings date for Citius Pharmaceuticals Inc?
The upcoming earnings date for Citius Pharmaceuticals Inc is May 10, 2024.
Click to get the best stock tips daily for free!

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected c... CTXR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT